Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

0.69 (USD) • At close July 3, 2025
Bedrijfsnaam Verrica Pharmaceuticals Inc.
Symbool VRCA
Munteenheid USD
Prijs 0.689
Beurswaarde 63,763,295
Dividendpercentage 0%
52-weken bereik 0.382 - 8.98
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ted White
Website https://www.verrica.com

An error occurred while fetching data.

Over Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is

Vergelijkbare Aandelen

Movano Inc. logo

Movano Inc.

MOVE

0.68 USD

Lumos Pharma, Inc. logo

Lumos Pharma, Inc.

LUMO

4.34 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Curis, Inc. logo

Curis, Inc.

CRIS

1.81 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

12.5 USD

Mustang Bio, Inc. logo

Mustang Bio, Inc.

MBIO

1.21 USD

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

6.395 USD

Neuronetics, Inc. logo

Neuronetics, Inc.

STIM

3.4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)